Skip to content

Moxibustion at Shenque for early onset of lactogenesis II and it's mechanism in cesarean delivery mothers: a randomized controlled trial

Moxibustion at Shenque for early onset of lactogenesis II and it's mechanism in cesarean delivery mothers: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020335
Enrollment
Unknown
Registered
2018-12-24
Start date
2018-12-24
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean infant's breastfeeding

Interventions

control group:normal nursing care
Experimental group :Moxibustion shenque point

Sponsors

Wannan Medical College First Affiliated Hospital, Yijishan Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-35 years; 2. Finish cesarean delivery and keep stable vital signs; 3. The delivery was not initiated before cesarean section; 4. Single birth of the first or second child; 5. Full-term deliveries of normal newborns (newborns born at 37-42 weeks gestation age, bodyweight more than 2500g, and without abnormalities and diseases, Apgar score = 8 for newborns 1 minute and 5 minutes after birth); 6. Willing to breast-feed babies; 7. Voluntary participation in the study.

Exclusion criteria

Exclusion criteria: 1. Breast-feeding contraindications or psychiatric problems; 2. Complications related to pregnancy or childbirth; 3. Diseases and drugs that affect the white blood cells count and its differential counts; 4. A fever (temperature =38.0 degree C) within 48 hours postpartum; 5. Mother and infant separation after delivery; 6. Emergency cesarean section (after onset of labour); 7. A pregestational body mass index (BMI) =28 kg/m2 (obesity); 8. Smoking during pregnancy; 9. The mother's breast factor may cause insufficient lactation; 10. Drugs such as levodopa, bromoergocycline, reserpine and phenothiazine may affect prolactin levels; 11. Puerperae of red tongue with no coating or yellow coating who are not suitable for moxibustion.

Design outcomes

Primary

MeasureTime frame
onset of lactogenesis II;

Countries

China

Contacts

Public ContactShenghong He

Wannan Medical College First Affiliated Hospital, Yijishan Hospital

hesh200451@163.com+86 13275539157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026